Invention Grant
- Patent Title: Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof
- Patent Title (中): 含有普拉克索或其药学上可接受的盐的延长释放丸剂制剂
-
Application No.: US12630271Application Date: 2009-12-03
-
Publication No.: US08715728B2Publication Date: 2014-05-06
- Inventor: Thomas Friedl , Rolf-Stefan Brickl
- Applicant: Thomas Friedl , Rolf-Stefan Brickl
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Michael P. Morris; Philip I. Datlow
- Priority: EP04019249 20040813
- Main IPC: A61K9/22
- IPC: A61K9/22 ; A61K9/62 ; A61K9/58 ; A61K9/16 ; A61K9/50 ; A61K31/425
Abstract:
An extended release pellet comprising an active ingredient selected from pramipexole and the pharmaceutically acceptable salts thereof, and at least one release-modifying excipient.
Public/Granted literature
- US20100086589A1 EXTENDED RELEASE PELLET FORMULATION CONTAINING PRAMIPEXOLE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF Public/Granted day:2010-04-08
Information query
